CHAIR
:
SPEAKER
(S):
Michael Lytton, General Partner, Oxford BioSciences Partners
Laura Berezin, Partner, Cooley Godward LLP
Annette C. Grimaldi, Managing Director, Head of Life Sciences Group, Jefferies & Company, Inc.
Chuck Abdalian, Sr. Vice President, Finance and Chief Financial Officer, Coley Pharmaceutical Group, Inc.
Description
This panel will offer experienced guidance from the executive, operational and legal perspectives on undertaking and surviving the process of becoming a public company. The topics discussed by our panel of CEOs, investors and corporate advisers will cover the process from start to finish.
Objectives:
Discuss the steps and protocols to prepare a private company to be public.
Outline what to expect during the execution process.
Discuss life after the IPO.